[Form 4] IPERIONX Ltd Insider Trading Activity
Rhea-AI Filing Summary
Arima Anastasios reported acquisition or exercise transactions in this Form 4 filing.
IPERIONX Ltd Chief Executive Officer Anastasios Arima received multiple new equity awards. On 2026-04-02, he was granted 237,944 performance rights tied to an A$18.00 stock-price hurdle and four years of continuous service, each convertible into one ordinary share once the performance criteria are met.
He was also granted options over 564,759 IPX ordinary shares at A$18.00 and 639,205 shares at A$22.00, each exercisable from 2030-04-02 and expiring on 2031-04-02. These are compensation-related awards, not open-market share purchases or sales.
Following these grants, Arima holds 12,206,782 ordinary shares directly, 128,000 American Depository Shares listed on Nasdaq (each equal to ten ordinary shares), 435,806 performance rights at each of A$6.00, A$7.00 and A$8.00, and 738,576 restricted stock units.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Performance Rights (A$18) | 237,944 | $0.00 | -- |
| Grant/Award | Options (A$18) | 564,759 | $18.00 | $10.17M |
| Grant/Award | Options (A$22) | 639,205 | $22.00 | $14.06M |
| holding | American Depository Shares (ADS) | -- | -- | -- |
| holding | Performance Rights (A$6) | -- | -- | -- |
| holding | Performance Rights (A$7) | -- | -- | -- |
| holding | Performance Rights (A$8) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
Footnotes (1)
- Ordinary Shares are traded on the Australian Stock Exchange (ASX). 318,666 vest in December 2026; 419,910 vest in April 2028. American Depository Shares are traded on the Nasdaq. One ADS is equivalent and exchangeable into ten ordinary shares. Australian Dollars Each performance right is convertible into one ordinary share after performance criteria have been met. Performance criteria are (1) four years of continuous service through 04/02/2030, and (2) IPX stock price on the ASX reaching a thirty-day volume-weighted average price (VWAP) of A$18.00. Each option confers the right to purchase one ordinary share at the conversion price.